 | Biohaven Pharmaceutical (NYSE:BHVN) Sets New 1-Year High at $152.10
americanbankingnews.com - September 25 at 4:14 AM |
 | Real-World Administrative Claims Analysis Demonstrates That Almost Half of Migraine Patients Discontinue Barbiturate Use After Initiation of Nurtec ODT
finance.yahoo.com - August 31 at 10:38 AM |
 | Biohaven Pharmaceutical's Return On Capital Employed Overview
msn.com - August 26 at 4:49 PM |
 | Biohaven: Non-Standard Merger Consideration Makes This A Buy
seekingalpha.com - August 17 at 12:18 PM |
| Why These Pfizer Analysts Like The Global Blood Therapeutics Deal
msn.com - August 10 at 11:58 AM |
| Get ready for more merger mania in the pharma sector for the rest of the year
finance.yahoo.com - August 9 at 4:53 PM |
| Biohaven Pharmaceutical (BHVN) Q2 Earnings Lag, Sales Beat
finance.yahoo.com - August 8 at 3:48 PM |
| Biohaven Reports Second Quarter 2022 Financial Results and Reports Recent Business Developments
finance.yahoo.com - August 5 at 8:14 AM |
| ClearBridge Investments Trimmed its Position in Biohaven Pharmaceutical (BHVN)
finance.yahoo.com - August 3 at 9:11 PM |
 | SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates COWN, SWIR, BHVN, GLTA
apnews.com - August 3 at 11:10 AM |
 | Notable ETF Outflow Detected - IWM, BHVN, SWAV, HALO
nasdaq.com - July 28 at 7:54 PM |
|
| American Migraine Foundation Survey Shows Nearly All People with Migraine and Healthcare Professionals Believe Migraine and Mental Health Significantly Impact Each Other
finance.yahoo.com - July 28 at 8:52 AM |
| The M&A Class Action Firm Continues Investigating the Merger
apnews.com - July 26 at 2:31 PM |
| Noteworthy Tuesday Option Activity: BHVN, F, SI
nasdaq.com - July 19 at 8:28 PM |
| IWM, BHVN, SWAV, HALO: Large Outflows Detected at ETF
nasdaq.com - July 16 at 9:24 PM |
| INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, GRRB, SIMO, MN
apnews.com - July 13 at 2:14 PM |
| Biohaven Enrolls First Patient in Phase 3 Trial of Taldefgrobep alfa in Spinal Muscle Atrophy (SMA)
finance.yahoo.com - July 7 at 7:43 AM |
| Biohaven Pharmaceutical Holding Co Ltd - Stock News
morningstar.com - July 7 at 2:33 AM |
| INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, MANT, PCSB, NLSN
apnews.com - July 7 at 2:33 AM |
| Pfizer Stock: Plenty Left in the Vial Despite COVID-19 Waning
nasdaq.com - June 29 at 6:16 AM |
| INVESTIGATION NOTICE: Halper Sadeh LLP Investigates BHVN, USWS, HR, SREV
apnews.com - June 28 at 3:15 PM |
| AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention
finance.yahoo.com - June 22 at 4:41 PM |
| Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Up 2.8% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - June 9 at 4:55 PM |
| Biohaven Underscores Depth of Migraine Portfolio with Data from Nurtec® ODT (rimegepant) Long-Term Open Label Study and Phase 3 Zavegepant Trial at 64th Annual Scientific Meeting of the American Headache Society
finance.yahoo.com - June 9 at 11:55 AM |
| SHAREHOLDER UPDATE: Halper Sadeh LLP Investigates HMTV, BHVN, MANT, SWCH
apnews.com - June 6 at 12:50 PM |
 | SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, MANT, SWCH
markets.businessinsider.com - June 1 at 6:56 AM |
| Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN): Is Breakeven Near?
finance.yahoo.com - May 24 at 4:38 PM |
| Biohaven's (BHVN) Zavegepant NDA for Migraine Accepted by FDA
finance.yahoo.com - May 24 at 11:36 AM |
| Biogen Needs a New CEO. Here Are Some Options.
finance.yahoo.com - May 24 at 11:36 AM |
 | Biohaven's drug for genetic neurological disease fails late-stage study
reuters.com - May 23 at 10:23 PM |
| SHAREHOLDER ALERT: Halper Sadeh LLP Investigates BHVN, SWCH, TREC, MICT
apnews.com - May 23 at 5:23 PM |
| Biohaven gets FDA review for nasal spray zavegepant to treat migraine
seekingalpha.com - May 23 at 5:23 PM |
|
| Biohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progression
seekingalpha.com - May 23 at 5:23 PM |
| US FDA Accepts for Review Biohaven's New Drug Application (NDA) Filing of Intranasal Zavegepant for the Acute Treatment of Migraine
finance.yahoo.com - May 23 at 5:23 PM |
| UPDATE 2-Biohaven's drug for neurological disease fails late-stage study
finance.yahoo.com - May 23 at 5:23 PM |
| Biohaven's Neurological Disease Candidate Flunks In Late-Stage Study
finance.yahoo.com - May 23 at 5:23 PM |
| Global Blood, Impel Pharma could be M&A targets after Biohaven deal - analysts
seekingalpha.com - May 15 at 6:07 PM |
 | Shareholder Alert - The M&A Class Action Firm Announces an Investigation of BioHaven Pharmaceutical Holding Company Ltd. - BHVN
benzinga.com - May 13 at 10:59 PM |
| Pfizer Turns to Unusual Deal Structure to Buy Biohaven Drugs
finance.yahoo.com - May 13 at 4:12 AM |
| January 2023 Options Now Available For Biohaven Pharmaceutical Holding (BHVN)
nasdaq.com - May 11 at 3:06 PM |
| Pfizer is Acquiring a Migraine Fixer for $11.6 Billion
finance.yahoo.com - May 11 at 12:23 AM |
| BIOHAVEN ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of BHVN and Encourages Investors to Contact the Firm
benzinga.com - May 10 at 7:23 PM |
| Nasdaq Leads Upside As Indexes Pull Back Into The Close; This Dow Jones Stock Nears Buy Point
finance.yahoo.com - May 10 at 7:23 PM |
 | Why Is Biohaven Pharmaceutical (BHVN) Stock Up Today?
investorplace.com - May 10 at 6:03 PM |
 | Pfizer splashes $11.6bn of vaccine cash on Biohaven Pharmaceutical Holding
proactiveinvestors.com.au - May 10 at 2:22 PM |
| BHVN Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Sale of Biohaven Pharmaceutical to Pfizer
apnews.com - May 10 at 2:22 PM |
| Pfizer to acquire HBM portfolio company Biohaven Pharmaceuticals in USD 11.6 billion deal
markets.businessinsider.com - May 10 at 2:22 PM |
| Pfizer Buys Biohaven In A $12 Billion Deal That 'Couldn't Have Come At A Better Time'
finance.yahoo.com - May 10 at 2:22 PM |
| Stock Market Fades, Mixed At Midday; A Defensive Group Sells Off
finance.yahoo.com - May 10 at 2:22 PM |
| Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
markets.businessinsider.com - May 10 at 8:17 AM |
